Dialysis News and Research

Latest Dialysis News and Research

Vital Access launches SAVE-2 post-market clinical follow-up study

Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.

10 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013.

5 Oct 2013

Taking multivitamin daily may reduce incidence of cancer in men

Major diseases that stem from vitamin deficiencies are rare in the U.S., where food is abundant and rich in vital nutrients, explains David J. Park, DO, an AOA board-certified family physician in Henderson, Nev., during the American Osteopathic Association's (AOA) OMED 2013, the Osteopathic Medical Conference & Exposition taking place this week in Las Vegas.

5 Oct 2013

Component of grape, citrus fruits block formation of kidney cysts

A new study published today in British Journal of Pharmacology has identified that a component of grapefruit and other citrus fruits, naringenin, successfully blocks the formation of kidney cysts.

3 Oct 2013

Study explains why survival is low in peritoneal dialysis patients

Clinicians and scientists from Keele and Cardiff universities have published data from a landmark study that explains why survival in patients on peritoneal dialysis is low.

23 Sep 2013

Vital Access reports first commercial implantation of VWING vascular needle guide in patient

Vital Access today announced the first U.S. commercial implantation of their VWING™ Vascular Needle Guide, in a patient presenting with cannulation challenges and with difficulties in achieving ideal dialysis access due to the depth and tortuosity of their AV fistula.

21 Sep 2013

Researchers identify two accurate predictors of short-term mortality

Having the right tool to estimate surgical risk in patients at high risk for complications and death during and after surgery is crucially important, according to a study in the October issue of Anesthesiology.

19 Sep 2013

Winners of Renal Support Network's Annual Essay Contest announced

Now in its 11th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its Annual Essay Contest.

18 Sep 2013

Large numbers of kidney disease patients inappropriately prescribed statins to lower cholesterol

A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol - drugs that offer them no benefit and may increase other health risks such as diabetes, dementia or muscle pain.

11 Sep 2013

Combination of Baxter and Gambro enable Baxter to better serve innovative renal products and therapies

Baxter International Inc. (NYSE: BAX) today announced that the company has successfully completed the acquisition of Gambro AB, a privately held global medical technology company and leader in dialysis products based in Lund, Sweden.

From Baxter International Inc. 7 Sep 2013

First Edition: September 6, 2013

Today's headlines include a report on the White House's proposal about how to gather information that would allow the government to enforce the employer mandate, which requires companies with 50 or more workers to provide affordable health insurance to their full-time employees.

6 Sep 2013

New gene that causes cystic kidneys in children, young adults identified

Sylvia Hoff, a graduate student from the Spemann Graduate School of Biology and Medicine, has identified a new gene that causes cystic kidneys in children and young adults.

6 Sep 2013

Preventive PCI for patients with ST elevation myocardial infarction results in better outcomes

Heart attack patients with ST elevation who undergo a preventive procedure to unblock additional coronary arteries have significantly better outcomes than those whose treatment is confined to the culprit blockage only, according to the results of the Preventive Angioplasty in Myocardial Infarction (PRAMI) Trial

5 Sep 2013

Anti-diabetic drug alogliptin meets primary endpoint in EXAMINE trial

Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according to results of the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial presented at the European Society of Cardiology Congress.

2 Sep 2013

After voting to cut payments to dialysis clinics, many lawmakers seek a reversal

On Capitol Hill, some lawmakers are rethinking the Medicare policy for kidney patients because clinics argue they may have to close or cut services. Elsewhere, the president of the American Medical Association is optimistic Congress will change Medicare's payment formula and a Republican senator wants all congressional staff to get coverage in Obamacare's exchanges.

30 Aug 2013

First Edition: August 29, 2013

Today's headlines include reports about ongoing fiscal fights surrounding efforts to raise the nation's debt limit and to defund the health law. Also, the White House enlists former President Bill Clinton to help spread the word about the overhaul.

29 Aug 2013

Scientists grow cells that line blood vessels from human iPSCs

In a scientific first, Harvard Stem Cell Institute scientists have successfully grown the cells that line the blood vessels-called vascular endothelial cells-from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.

23 Aug 2013

Medicare changes appear to be driving reduced used of dialysis drugs

The Washington Post reports on a new study, which finds Food and Drug Administration warnings did not cause a sharp drop in the use of these drugs.

16 Aug 2013

New microfluidic chip can capture live CTCs from patient's blood

Tumor cells circulating within a patient's bloodstream can carry cancer from a primary tumor site to distant sites of the body, spreading the disease.

9 Aug 2013